Trial Details

COMPLETED
Basic Information
Clinical ID c1559
Identifier NCT01201122
Trial Title Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Mild to Moderate Ulcerative Colitis
Interventions DRUG: Mesalamine
Participant Information
Sponsor Wolfson Medical Center
City Holon
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-09-10
Primary Completion Date 2025-12-15
Completion Date 2025-12-15